March 2024
Los Angeles, CA (March 2024) – Avante Capital Partners, a majority women and minority-owned private credit and structured equity firm, is delighted to announce a successful debt financing in support of Ampersand Capital Partners’ acquisition of Biologos.
Founded in 1976 and based in Glendale Heights, IL, Biologos is a manufacturer of custom and standard sterile-filtered cell culture media, serum, buffers, and reagents with a focus on animal health, tissue processing, diagnostics, and biopharmaceutical end markets.
“We are thrilled to embark on this transformative journey with Ampersand and Biologos,” said David Ng, Principal at Avante Capital Partners. “We believe that Biologos’ innovative approaches will continue to offer best-in-class cell culture media solutions to customers. We are committed to supporting Biologos in achieving its strategic objectives and look forward to the continued achievements made by the company.”
About Avante
Avante Capital Partners is a majority-owned women- and minority-owned private credit and structured equity fund headquartered in Los Angeles. Avante invests in the form of senior/1L debt, unitranche debt, mezzanine debt and minority equity in high-quality, lower middle market businesses generating at least $3 million in cash flow.